280 related articles for article (PubMed ID: 8911290)
1. Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario.
Sergeant MD; Hodgetts PG; Godwin M; Walker DM; McHenry P
CMAJ; 1996 Nov; 155(9):1243-8. PubMed ID: 8911290
[TBL] [Abstract][Full Text] [Related]
2. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
Hodges B
CMAJ; 1995 Sep; 153(5):553-9. PubMed ID: 7641153
[TBL] [Abstract][Full Text] [Related]
3. Residents' perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention.
Schneider JA; Arora V; Kasza K; Van Harrison R; Humphrey H
Acad Med; 2006 Jul; 81(7):595-602. PubMed ID: 16799279
[TBL] [Abstract][Full Text] [Related]
4. [Attitudes and behaviors of psychiatry residents and psychiatrists working in training institutes towards the relationship between the pharmaceutical industry and physicians].
Gülöksüz S; Oral ET; Ulaş H
Turk Psikiyatri Derg; 2009; 20(3):236-42. PubMed ID: 19757223
[TBL] [Abstract][Full Text] [Related]
5. Attitudes and behaviors of psychiatry residents toward pharmaceutical representatives before and after an educational intervention.
Randall ML; Rosenbaum JR; Rohrbaugh RM; Rosenheck RA
Acad Psychiatry; 2005; 29(1):33-9. PubMed ID: 15772402
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical policies in Canadian family medicine training. Survey of residency programs.
Mahood S; Zagozeski C; Bradel T; Lawrence K
Can Fam Physician; 1997 Nov; 43():1947-51. PubMed ID: 9386881
[TBL] [Abstract][Full Text] [Related]
7. Policies regulating the activities of pharmaceutical representatives in residency programs.
Brotzman GL; Mark DH
J Fam Pract; 1992 Jan; 34(1):54-7. PubMed ID: 1728655
[TBL] [Abstract][Full Text] [Related]
8. [Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry].
Gundermann C; Meier-Hellmann A; Bauer M; Hartmann M
Dtsch Med Wochenschr; 2010 May; 135(3):67-70. PubMed ID: 20077378
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with physicians' reliance on pharmaceutical sales representatives.
Anderson BL; Silverman GK; Loewenstein GF; Zinberg S; Schulkin J
Acad Med; 2009 Aug; 84(8):994-1002. PubMed ID: 19638762
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical industry support and residency education: a survey of internal medicine program directors.
Loertscher LL; Halvorsen AJ; Beasley BW; Holmboe ES; Kolars JC; McDonald FS
Arch Intern Med; 2010 Feb; 170(4):356-62. PubMed ID: 20177039
[TBL] [Abstract][Full Text] [Related]
11. Medical abortion and family physicians. Survey of residents and practitioners in two Ontario settings.
Raymond E; Kaczorowski J; Smith P; Sellors J; Walsh A
Can Fam Physician; 2002 Mar; 48():538-44. PubMed ID: 11935718
[TBL] [Abstract][Full Text] [Related]
12. Clinical practice guidelines. New-to-practice family physicians' attitudes.
Ferrier BM; Woodward CA; Cohen M; Williams AP
Can Fam Physician; 1996 Mar; 42():463-8. PubMed ID: 8616286
[TBL] [Abstract][Full Text] [Related]
13. Practice choices of graduating family medicine residents.
Godwin M; Hodgetts G; Wilson R; Pong R; Najgebauer E
Can Fam Physician; 1998 Mar; 44():532-6. PubMed ID: 9559193
[TBL] [Abstract][Full Text] [Related]
14. Psychiatric resident and faculty views on and interactions with the pharmaceutical industry.
Misra S; Ganzini L; Keepers G
Acad Psychiatry; 2010; 34(2):102-8. PubMed ID: 20224017
[TBL] [Abstract][Full Text] [Related]
15. Knowledge of medical-legal issues. Survey of Ontario family medicine residents.
Saltstone SP; Saltstone R; Rowe BH
Can Fam Physician; 1997 Apr; 43():669-73. PubMed ID: 9111983
[TBL] [Abstract][Full Text] [Related]
16. A study of interactions between pharmaceutical representatives and ophthalmology trainees.
Wang Y; Adelman RA
Am J Ophthalmol; 2009 Oct; 148(4):619-622.e3. PubMed ID: 19570520
[TBL] [Abstract][Full Text] [Related]
17. Development of residency program guidelines for interaction with the pharmaceutical industry. Education Council, Residency Training Programme in Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ont.
CMAJ; 1993 Aug; 149(4):405-8. PubMed ID: 8348422
[TBL] [Abstract][Full Text] [Related]
18. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
Brett AS; Burr W; Moloo J
Arch Intern Med; 2003 Oct; 163(18):2213-8. PubMed ID: 14557219
[TBL] [Abstract][Full Text] [Related]
19. Structured approach to pharmaceutical representatives. Family medicine residency program.
Kelcher S; Brownoff R; Meadows LM
Can Fam Physician; 1998 May; 44():1053-6, 1059-60. PubMed ID: 9612591
[TBL] [Abstract][Full Text] [Related]
20. Proposed model for interaction between residents and residency training programs, and pharmaceutical industry.
Razack S; Arbour L; Hutcheon R
Ann R Coll Physicians Surg Can; 1999 Mar; 32(2):93-6. PubMed ID: 12378718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
